Multi-Omics Profiling
We analyze a wide range of biomolecules across different sample types, including:
- RNA Sequencing (mRNA, lncRNA, small RNA, microRNA): It identifies gene expression signatures, splice variants, and mutations linked to disease or treatment response.
- Exosomal RNA Analysis: It detects circulating biomarkers from biofluids, offering insights into tissue-specific disease mechanisms.
- cfDNA Methylation & Bisulfite Sequencing: It evaluates epigenetic modifications in tissue, gDNA, or liquid biopsies for cancer and other complex diseases.
- Metatranscriptomics: It Profiles microbial RNA to uncover host-microbiome interactions affecting drug efficacy.
High-Sensitivity Detection Technologies
Our high-sensitivity detection technologies empower researchers to uncover rare and low-abundance biomarkers with exceptional accuracy, supporting early diagnosis, therapeutic monitoring, and precision medicine development.
- Tumor Panels (NGS-Based): Our ultra-deep NGS-based tumor panels enable sensitive detection of low-frequency variants, including mutations, fusions, INDELs, and SNPs, with allele frequencies as low as 1%.
- MicroRNA Profiling: Using high-performance microarray platforms and proprietary protocols, we detect low-abundance circulating and exosomal microRNAs critical for early diagnosis and therapeutic targeting.
- Immunoassays: Our customizable immunoassays offer picogram-level sensitivity, quantifying up to 60 analytes across key pathways such as angiogenesis, immune regulation, and metastasis, supporting biomarker validation and translational research.
Predictive Modeling & Bioinformatics
- Our predictive modeling and bioinformatics services integrate multi-omics data to identify robust biomarkers associated with diagnosis, prognosis, and treatment response.
- Using advanced algorithms, machine learning, and curated pipelines, we uncover clinically relevant patterns and actionable insights from complex datasets.
- We support data interpretation, visualization, and hypothesis generation to accelerate biomarker discovery and translational research.
- Our expert team ensures precise analysis and post-project guidance, facilitating confident decision-making throughout the drug development and diagnostic pipeline.
Post-Service Support
To ensure seamless translation from discovery to application, we provide:
- Bioinformatics & Data Interpretation: Advanced pipelines for differential expression, pathway analysis, and biomarker validation.
- Companion Diagnostic (CDx) Development: Streamlined workflows to reduce attrition rates and shorten time-to-market.
